SPC Financial Inc’s Gilead Sciences GILD Stock Holding History

SPC Financial Inc’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$659K	Buy	5,934 +32	+0.5%	+$3.64K	0.05%	153
2025 Q2	$654K	Buy	5,902 +122	+2%	+$13K	0.05%	150
2025 Q1	$648K	Buy	5,780 +100	+2%	+$10.3K	0.06%	151
2024 Q4	$525K	Buy	5,680 +150	+3%	+$13.5K	0.05%	161
2024 Q3	$464K	Buy	5,530 +550	+11%	+$42K	0.04%	183
2024 Q2	$342K	Buy	4,980 +768	+18%	+$51.3K	0.03%	189
2024 Q1	$309K	Buy	4,212 +400	+10%	+$30.8K	0.03%	193
2023 Q4	$309K	Buy	3,812 +180	+5%	+$14K	0.03%	185
2023 Q3	$272K	Buy	3,632 +127	+4%	+$9.77K	0.03%	188
2023 Q2	$270K	Buy	+3,505	New	+$280K	0.03%	190

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SPC Financial Inc's GILD Position: Q3 2025 in Review

SPC Financial Inc increased its Gilead Sciences (GILD) stake by 0.54% in Q3 2025, buying an estimated $3.64K and bringing the position to 5,934 shares worth $659K. The position accounts for 0.05% of the portfolio, ranked #153.

SPC Financial Inc first reported a position in GILD in Q2 2023 and has held it in 10 quarters since. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

SPC Financial Inc held 5,934 shares of Gilead Sciences worth $659K as of Q3 2025.
SPC Financial Inc bought 32 Gilead Sciences shares in Q3 2025, an estimated $3.64K.
Gilead Sciences made up 0.05% of SPC Financial Inc's portfolio in Q3 2025, its #153 holding.
SPC Financial Inc first reported a position in Gilead Sciences in Q2 2023 and has held it in 10 quarters since.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on SPC Financial Inc's 13F filing for Q3 2025, filed 5 Nov 2025.